HIPAA-aligned AI infrastructure for health systems that refuse to rent their patient intelligence.

Yes. OrenGen Worldwide LLC is BAA-ready and executes Business Associate Agreements as part of standard engagement onboarding with covered entities and other business associates. BAA execution happens before any PHI-touching scope of work begins. The firm operates HIPAA-Enabled Architecture on a SOC 2 Type 2 attested platform layer, and maintains a HIPAA Workforce Attestation covering 30 members as of 2026.

PHI residency stays under the Counterpart’s control by default. OrenHealth’s architecture supports behind-firewall and private-cloud deployments where PHI does not traverse third-party model training pipelines. Encryption at rest and in transit, role-based access controls, comprehensive audit trail architecture, and minimum-necessary data exposure patterns are deployed standard. PHI flow documentation is produced as part of the deployment scope.

The architecture is aligned to HIPAA Security Rule technical safeguards — access controls including unique user identification and emergency access procedure, audit controls including hardware and software audit trail architecture, integrity controls protecting PHI from improper alteration, person or entity authentication, and transmission security including encryption in transit and at rest. Workforce training and BAA execution support the administrative and organizational safeguards layer.

Yes. OrenHealth’s Legacy EHR Modernization pillar wraps existing electronic health record, electronic medical record, and practice management systems with AI capability through documented API integration patterns. The firm does not rip and replace existing clinical investment. Common integration patterns cover documentation assistance, prior authorization automation, referral routing, patient portal augmentation, and revenue cycle workflow.

The platform layer OrenHealth operates on holds SOC 2 Type 2 attestation. OrenGen-direct SOC 2 Type 1 is on the 2026 roadmap, with HITRUST evaluation following. The firm cites these as roadmap items rather than claimed credentials. Counterparts whose procurement requirements name direct SOC 2 or HITRUST certification as a hard gate are informed of the firm’s current posture at the briefing stage so timing expectations are set honestly.

Research data residency stays under the research organization’s control. OrenHealth’s behind-firewall deployment pattern supports clinical trial data that must remain inside the institutional perimeter for regulatory or IRB reasons. EU-US Data Privacy Framework and Swiss-US DPF participation supports international research collaborations. De-identification, limited data set workflows, and minimum-necessary access patterns are part of the standard architecture vocabulary.

Patient communication infrastructure is built around HIPAA marketing rules, TCPA consent requirements, and state-level outreach restrictions. Appointment reminders, treatment-related communications, and care coordination messages follow consent-based and treatment-payment-operations boundaries. Marketing communications require explicit authorization. Audit trails of consent capture and message delivery are produced and retained per the organization’s retention schedule.